Serialized Print Is Becoming the Backbone of Anti-Counterfeit Packaging

Anti-counterfeit packaging is no longer a niche feature reserved for a handful of high-risk products. It is turning into a broader packaging requirement because the problem it is trying to solve keeps getting bigger, more global, and more expensive. Counterfeit trade still reaches deep into legitimate commerce, and the pressure now comes from several directions at once: pharmaceutical crime, e-commerce fraud, stricter traceability rules, retailer and marketplace verification programs, and rising expectations that brands should be able to prove a product is genuine at the unit level.

That combination matters for packaging because most anti-counterfeit systems eventually have to touch the pack. Some use RFID. Some use tamper evidence. Some rely on cloud verification, track-and-trace software, or consumer-facing apps. Some use digital signatures or blockchain-backed records. But before any of that can work in the real world, the product usually needs a unique identity that can be applied, read, and verified on the package itself. That is why serialization keeps moving to the center of the discussion.

A useful way to understand the shift is this: anti-counterfeiting is increasingly becoming a data problem before it becomes a security problem. The package is no longer just carrying branding and compliance text. It is carrying an identifier that is supposed to distinguish one unit from every other unit, connect that unit to a system of record, and support authentication somewhere along the supply chain. Once brands and regulators start expecting that level of precision, the pack has to do more than look correct. It has to be uniquely correct.

That is a big reason the anti-counterfeit packaging market keeps growing. The market research can vary by methodology, but the direction is clear and not hard to explain. The latest 2026 outlook from MarketsandMarkets projects the anti-counterfeit packaging market to grow from about $227.65 billion in 2026 to $316.7 billion by 2031, with pharmaceutical demand, stricter packaging rules, retailer adoption, and brand-protection concerns acting as major drivers. In that same outlook, pharmaceuticals are the largest end-use segment, while RFID is the fastest-growing technology segment. That lines up with what the industry is actually facing: more regulated goods, more serialized units, and more pressure to verify product identity earlier and more often.

Pharmaceuticals remain the clearest example because the stakes are obvious. The World Health Organization says substandard and falsified medical products affect people around the world, and it continues to cite the estimate that at least one in ten medicines in low- and middle-income countries are substandard or falsified. WHO also points to an estimated annual economic burden of $30.5 billion and emphasizes that these products can contain the wrong ingredients, the wrong dosage, or dangerous contaminants. Interpol’s recent enforcement activity shows the scale is not abstract. Operation Pangea XVII, conducted across 90 countries from late 2024 into 2025, resulted in the seizure of 50 million doses of illicit pharmaceuticals, the arrest of 769 suspects, and the dismantling of 123 criminal groups. Europol has also warned that criminal networks exploit both consumers and legitimate industry through counterfeit medicines. Even individual product categories can trigger high-profile alerts, as seen in WHO’s 2024 warning about falsified Ozempic detected in multiple countries, including products that entered regulated channels.

The lesson for packaging is blunt: where profit incentives are high and supply chains are complex, counterfeiters get better. The response has been to make identification and verification more systematic. In pharmaceuticals, regulations already moved the market in that direction years ago. In the United States, the Drug Supply Chain Security Act lays out the path to an interoperable, electronic way to identify and trace certain prescription drugs at the package level. FDA guidance spells out what that means on-pack: the product identifier includes a standardized numerical identifier, lot number, and expiration date in both human-readable form and a machine-readable 2D Data Matrix barcode. In the European Union, the Falsified Medicines Directive and Delegated Regulation 2016/161 require safety features that support authenticity verification, including a unique identifier in a 2D Data Matrix and print quality that remains readable through the supply chain. The EU regulation even presumes compliance when Data Matrix print quality reaches a defined minimum rating under ISO/IEC 15415.

That last part is easy to overlook, but it is the real production story. Anti-counterfeit packaging does not stop at “generate a serial number.” A serialization project is only as strong as the printed mark on the pack. If the code is unreadable, poorly placed, distorted, low-contrast, or inconsistent across substrates and line speeds, the entire verification chain weakens. The database may be perfect, the software may be integrated, and the authentication workflow may be well designed, but if scanners cannot reliably capture the code, the system breaks at the first physical handoff.

That is why barcode quality has become more than a technical footnote. In the GS1 Healthcare US barcode-readiness work tied to DSCSA interoperability, the industry explicitly stressed that barcodes need to be applied in a standardized way so physical markings can support accurate movement through the healthcare supply chain and link correctly to serialized electronic data exchange. The findings also noted that poor barcode quality and placement can lead to improper identification, mis-shipments, lower operational efficiency, and product-availability issues. Put plainly, bad marks create real downstream damage.

The same logic is now spreading beyond heavily regulated pharma into broader retail and e-commerce channels. GS1’s Sunrise 2027 initiative is accelerating the move from traditional 1D barcodes to 2D codes that can carry more than a simple product identifier. GS1 guidance for retail points out that 2D barcode syntaxes such as GS1 element strings and GS1 Digital Link URIs can support batch or lot numbers, serial numbers, and expiration dates, while also linking to digital information. That matters for anti-counterfeiting because the modern code is not just a checkout symbol anymore. It can be the product identity, the traceability key, and the consumer-facing authentication doorway at the same time.

Amazon’s Transparency program shows how fast that concept is becoming operational. Amazon describes Transparency as a product serialization service and anti-counterfeiting program that assigns a unique code to every unit of an enrolled product. Those codes are scanned through the supply chain to help prevent counterfeit units from being listed, shipped, and sold. Amazon says the program now includes more than 90,000 brands and more than 2.7 billion product units verified as genuine. Just as important for packaging operations, Amazon also says brands can connect Transparency to their existing serial codes, which allows faster enrollment without changing existing packaging. That is a sign of where the market is headed: authentication is no longer a side program that lives outside packaging production. It is being pulled directly into artwork, coding, and print workflows.

That trend became even more concrete in May 2026, when Hybrid Software announced it had joined Amazon’s Transparency Service Provider Network. The company tied the announcement directly to advanced variable data printing, GS1 2D serialization, and packaging workflow automation. The interesting part is not the company announcement by itself. The interesting part is what it reveals about the market. Serialization is being integrated into routine packaging operations, not handled as a separate exception process. That is a major shift because it pushes anti-counterfeit packaging away from theory and into day-to-day production reality.

For DPi’s audience, that production reality is the real article. The story is not that brands are suddenly obsessed with flashy technology. The story is that every serious anti-counterfeit strategy eventually collides with print execution. RFID can add another layer. Blockchain can add event integrity. Tamper-evident features can add physical deterrence. Digital signatures can strengthen trust models. But the package still often needs a unique visible or scannable mark that is accurate, unique, readable, and verifiable. That is where high-resolution variable printing stops being a convenience and starts becoming infrastructure.

Converters and manufacturers that can print serialized marks cleanly onto labels, cartons, flexible packaging, or corrugated are in a stronger position as anti-counterfeit requirements expand. They can support item-level identity without relying entirely on preprinted inventory. They can adapt more easily when markets, retailers, or platforms impose new coding rules. They can produce the data layer later in the process, closer to the point of packout, which reduces obsolescence and gives brands more control. And they can make verification more dependable because a well-printed mark is easier to inspect, scan, and trust.

That is the cleanest way to frame the trend for a DPi newsletter. Anti-counterfeit packaging is growing, but the most practical takeaway is not hype about the newest security buzzword. It is that serialization is becoming normal, and serialization lives or dies on print quality. As regulations tighten, marketplaces verify more aggressively, and brands demand proof of authenticity at the unit level, the packaging line has to deliver more than data. It has to deliver data that survives the real world.

Sources

Market growth and technology direction

MarketsandMarkets, Anti-Counterfeit Packaging Market Report 2026-2031 — 2026 market size, 2031 forecast, pharma as the largest end-use segment, and RFID as the fastest-growing technology. 

MarketsandMarkets, RFID Anti-counterfeiting Packaging Market worth $110.1 billion by 2030 — summary of how RFID anti-counterfeit packaging combines tags, encrypted IDs, tamper-evident features, and verification platforms. 

Counterfeit trade and pharmaceutical crime

OECD, Mapping Global Trade in Fakes 2025 — estimate that counterfeit and pirated goods accounted for up to 2.3% of global trade and 4.7% of EU imports in 2021. 

World Health Organization, Substandard and falsified medical products — WHO’s 2024 fact sheet on the global scale, health risks, economic burden, and technological responses including track-and-trace and blockchain when paired with regulation. 

INTERPOL, Pharmaceutical crime operations — Operation Pangea XVII results, including 50 million doses seized, 769 suspects arrested, and 123 criminal groups dismantled. 

Europol, The threat of pharmaceutical crime in the EU and beyond — overview of how criminal networks exploit consumers and industry through counterfeit medicines. 

WHO, Medical Product Alert N°2/2024: Falsified OZEMPIC — example of a current, high-profile counterfeit medicine problem reaching multiple countries. 

Regulation and serialization requirements

FDA, Drug Supply Chain Security Act — overview of the U.S. requirement to identify and trace certain prescription drugs at the package level. 

FDA, Product Identifiers Under the Drug Supply Chain Security Act — details that DSCSA product identifiers include standardized numerical identifier, lot number, and expiration date in human-readable form and a machine-readable 2D Data Matrix barcode. 

European Commission, Falsified medicines — summary of EU safety-feature requirements and authenticity verification framework. 

European Commission, Delegated Regulation 2016/161 — official language on Data Matrix readability through the supply chain and minimum print quality expectations. 

EFPIA, IFPMA, and PhRMA, Serialization and Product Verification – Helping to Secure the Legal Supply Chain — industry position that no single solution prevents counterfeiting and that harmonized international standards such as GS1 are the efficient path forward. 

Retail, GS1, and marketplace adoption

GS1 US, What is GS1 Sunrise 2027? — official overview of the 1D-to-2D transition and the role of GS1 Digital Link. 

GS1, GS1 Digital Link — official standard summary describing encoding of identifiers alongside batch numbers, serial numbers, and expiry dates. 

GS1, 2D Barcodes at Retail Point-of-Sale Implementation Guideline — guidance that 2D barcode syntaxes can carry batch/lot number, serial number, and expiration date and may require system upgrades to use that additional data. 

Amazon, Transparency — official description of Transparency as a serialization-based anti-counterfeiting program, including unique codes on every unit, program scale, and the option to connect existing serial codes without changing packaging. 

Hybrid Software, Hybrid Software Joins Amazon’s Transparency Service Provider Network — May 2026 announcement linking Amazon Transparency, GS1 2D serialization, variable data printing, and packaging workflow automation. 

Why print quality matters

GS1 Healthcare US, Barcode Readability for DSCSA 2023 Interoperability — evidence that standardized barcode application matters and that barcode quality or placement problems can lead to misidentification, mis-shipments, and operational issues.